Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2010
10/21/2010WO2010120002A1 Black-lip pearl oyster egg extract, and method for assessing the productive effort of a black-lip pearl oyster using a black-lip pearl oyster egg extract-specific polyclonal antibody
10/21/2010WO2010119769A1 Method for evaluation of chronic stress
10/21/2010WO2010119704A1 Antibodies that specifically bind to a beta oligomers and use thereof
10/21/2010WO2010119693A1 Method of screening for insulin secretion-potentiating agents
10/21/2010WO2010119691A1 Diagnosis and treatment of cancer using anti-tmprss11e antibody
10/21/2010WO2010119501A1 Bodily fluid component analyzer
10/21/2010WO2010119495A1 Method and apparatus for measuring concentration of biological component
10/21/2010WO2010119403A2 Cellular electric stimulation mediated by piezoelectric nanotubes
10/21/2010WO2010119380A1 Microfluidic device comprising sensor
10/21/2010WO2010119362A1 Protein-based methods and compositions for the diagnosis of colorectal adenocarcinoma
10/21/2010WO2010119341A1 On-board control detection
10/21/2010WO2010119307A1 Method for stimulating antigen-specific t cell responses using accelerated co-cultured dendritic cells
10/21/2010WO2010119295A1 Biomarkers
10/21/2010WO2010119286A1 Alzheimer's disease
10/21/2010WO2010119261A1 Method for quantifying modified peptides
10/21/2010WO2010119164A1 Device and method for measuring the quantity of a flowing liquid
10/21/2010WO2010119162A1 Method for detecting copper complexes of chlorophyll in vegetable oils
10/21/2010WO2010119069A1 Selective ion transport device
10/21/2010WO2010119061A1 Method for determining the cbl-b expression
10/21/2010WO2010119033A1 Method for stimulating antigen-specific t cell responses using accelerated co-cultured dendritic cells
10/21/2010WO2010119003A1 Biomarker for monitoring patients
10/21/2010WO2010119001A1 Prostate cancer cell lines and their use in screening method
10/21/2010WO2010118991A1 Methods for selecting oocytes and competent embryos with high potential for pregnancy outcome
10/21/2010WO2010118890A1 B-lymphocyte targeting agents for use in a method for the treatment of a disease
10/21/2010WO2010118861A1 Homogeneous agglutination immunoassay method and kit for such method
10/21/2010WO2010118855A1 Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin
10/21/2010WO2010118754A1 Selective ion transport device
10/21/2010WO2010118525A1 Signature of secreted protein isoforms specific to ovarian cancer
10/21/2010WO2010118524A1 Sensitizing agents for cancer therapy, methods of use and methods for the identification thereof
10/21/2010WO2010118520A1 Process for tumour characteristic and marker set identification, tumour classification and marker sets for cancer
10/21/2010WO2010099543A3 Compositions and methods for detecting oral neoplasm
10/21/2010WO2010099328A3 Spatially-selective reflector structures, reflector disks, and systems and methods for use thereof
10/21/2010WO2010099137A3 In situ methods for monitoring the emt status of tumor cells in vivo
10/21/2010WO2010097553A3 Method for diagnosing vasculitis
10/21/2010WO2010096117A3 Methods of treating psychosis and schizophrenia based on polymorphisms in the erbb4 gene
10/21/2010WO2010094734A3 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
10/21/2010WO2010092488A3 Method for evaluating risk in multiple sclerosis
10/21/2010WO2010091692A3 Constitutively active mutants of gpcr 88 and uses thereof
10/21/2010WO2010087594A3 Cd93 or use of soluble fragment thereof
10/21/2010WO2010083484A3 System and method for characterization of oral, systemic and mucosal tissue utilizing raman spectroscopy
10/21/2010WO2010082790A3 Electroresponsive device for extending the life of biosensors, and a biosensor employing the same
10/21/2010WO2010079919A3 Method for screening matrix metalloproteinase
10/21/2010WO2010078511A3 Detection of oligosaccharides
10/21/2010WO2010067358A3 Methods and kits for direct detection and susceptibility profiling of beta-lactam resistant bacteria
10/21/2010WO2010065929A9 Method for diagnosing allergic reactions
10/21/2010WO2010062116A3 High resolution surface plasmon resonance sensor and sensor system thereof
10/21/2010WO2010057943A3 Analysis system for fuel analysis
10/21/2010WO2010053980A3 Dna integrity assay (dia) for cancer diagnostics, using confocal fluorescence spectroscopy
10/21/2010WO2010042890A3 Polypeptides that bind trail-ri and trail-r2
10/21/2010WO2010007391A9 Hexacyanoferrate modified electrode
10/21/2010WO2009149087A9 Method for distinguishing between kidney dysfunctions
10/21/2010WO2009120249A8 Detection of head and neck cancer using hypermethylated gene detection
10/21/2010US20100269180 Methods, compositions and transgenic models related to the interaction of t-cadherin and adiponectin
10/21/2010US20100268480 Method and system for measuring emission and quantifying emission source
10/21/2010US20100268477 Systems and Methods for Calibrating Physiological Characteristic Sensors
10/21/2010US20100268474 Methods, systems and computer program products for predicting responsiveness to a pharmaceutical therapy for obesity or evaluating investigational pharmaceutical agents
10/21/2010US20100268473 Methods, devices, and compositions for the highly-sensitive detection and identification of diverse molecular entities
10/21/2010US20100268472 Determination of single peak melting temperature by pcr analogy and double sigmoid equation
10/21/2010US20100267937 Cyanine Dye Labelling Reagents
10/21/2010US20100267930 SLO2 and SLO4, Novel Potassium Channel Proteins from Human Brain
10/21/2010US20100267842 Emulsions of Perfluorocarbons
10/21/2010US20100267816 Human anti-amyloid beta peptide antibody and fragment of said antibody
10/21/2010US20100267804 Differential expression of micrornas in nonfailing versus failing human hearts
10/21/2010US20100267771 Automated immunossay apparatus with flexible pick-up arm
10/21/2010US20100267737 4-phenylpiperazine derivatives with functionalized linkers as dopamine d3 receptor selective ligands and methods of use
10/21/2010US20100267646 Trophic Factor for the Treatment of Retinal Degenerative Diseases
10/21/2010US20100267642 Use of complex forms of calmodulin-like skin protein clsp
10/21/2010US20100267641 Prognostic tests for development of dermal stretch marks and implications for the preventative treatment thereof
10/21/2010US20100267617 Methods and compositions for mycoplasma pneumoniae exotoxins
10/21/2010US20100267609 Compounds which inhibit beta-secretase activity and methods of use thereof
10/21/2010US20100267596 Method for improving the hydrolysis stability of ionic liquids
10/21/2010US20100267586 siRNA targeting KRAS
10/21/2010US20100267585 Chemical ligation dependent probe amplification (CLPA)
10/21/2010US20100267577 Methods for high throughput and quantitative proteome analysis
10/21/2010US20100267569 Compositions, methods and kits for the diagnosis of carriers of mutations in the BRCA1 and BRCA2 genes and early diagnosis of cancerous disorders associated with mutations in BRCA1 and BRCA2 genes
10/21/2010US20100267300 Method for producing reactive cyclodextrins textile material provided with same, and use of said cyclodextrin derivatives
10/21/2010US20100267170 Robust, self-assembled, biocompatible films
10/21/2010US20100267169 Electromagnetic molecular sensors and methods of using same
10/21/2010US20100267168 Method for end titre determination and the evaluation thereof by means of an indirect immunoflurescence assay
10/21/2010US20100267167 Device for detection of molecules in biological fluids
10/21/2010US20100267166 Diagnostic detection device
10/21/2010US20100267165 Microelectronic sensor device for the detection of target particles
10/21/2010US20100267159 Simultaneous analysis of chlorides and sulfides by low pressure ion exclusion chromatography
10/21/2010US20100267158 Electronic Detectors Inside Nanofluidic Channels For Detection, Analysis, and Manipulation of Molecules, Small Particles, and Small Samples of Material
10/21/2010US20100267151 Misfolded protein sensor method
10/21/2010US20100267150 Hdm2 polypeptides
10/21/2010US20100267149 Methods of determining potency of chemically-synthesized oligonucleotides
10/21/2010US20100267148 Method for the determination of the position of unsaturation in a compound
10/21/2010US20100267138 Compositions and methods comprising a ligand of chemerinr
10/21/2010US20100267092 Components
10/21/2010US20100267077 method of measuring the ability of a sample to withstand reactive oxygen species (ross)
10/21/2010US20100267071 Solution phase homogeneous assays
10/21/2010US20100267069 Analysis of proteins from biological fluids using mass spectrometric immunoassay
10/21/2010US20100267068 Analysis of doping compounds
10/21/2010US20100267065 Apparatus and methods for analyzing fluid variables
10/21/2010US20100267064 Methods for quantitative target detection and related devices and systems
10/21/2010US20100267063 Methods and apparatuses for conducting assays
10/21/2010US20100267062 Osteopontin as Novel Prognostic Biomarker for Heart Failure
10/21/2010US20100267061 Detecting phospholipidosis and diagnosing lysosomal storage disorders
10/21/2010US20100267060 High sensitivity secretagogin assays and their uses for diagnosis and/or prognosis